The APOBEC3G Deamination Independent Mode of HIV Inhibition

Pulmonary dead space and survival. The New England Journal of Medicine. ,vol. 347, pp. 850- 852 ,(2002) , 10.1056/NEJM200209123471115

Tomohiro Morio, Masamichi Muramatsu, Shigeaki Nonoyama, Shuki Mizutani, Tasuku Honjo, Yi Zhu, Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. Journal of medical and dental sciences. ,vol. 50, pp. 41- 46 ,(2003) , 10.11480/JMDS.500106

C. Barat, V. Lullien, O. Schatz, G. Keith, M.T. Nugeyre, F. Grüninger-Leitch, F. Barré-Sinoussi, S.F. LeGrice, J.L. Darlix, HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. The EMBO Journal. ,vol. 8, pp. 3279- 3285 ,(1989) , 10.1002/J.1460-2075.1989.TB08488.X

Bastien Mangeat, Priscilla Turelli, Gersende Caron, Marc Friedli, Luc Perrin, Didier Trono, Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature. ,vol. 424, pp. 99- 103 ,(2003) , 10.1038/NATURE01709

Stuart F. J. GRICE, Fiona GRUNINGER-LEITCH, Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. FEBS Journal. ,vol. 187, pp. 307- 314 ,(1990) , 10.1111/J.1432-1033.1990.TB15306.X

Xiao-Yu Li, Fei Guo, Li Zhang, Lawrence Kleiman, Shan Cen, APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription. Journal of Biological Chemistry. ,vol. 282, pp. 32065- 32074 ,(2007) , 10.1074/JBC.M703423200

Linda Chelico, Courtney Prochnow, Dorothy A. Erie, Xiaojiang S. Chen, Myron F. Goodman, Structural Model for Deoxycytidine Deamination Mechanisms of the HIV-1 Inactivation Enzyme APOBEC3G Journal of Biological Chemistry. ,vol. 285, pp. 16195- 16205 ,(2010) , 10.1074/JBC.M110.107987

Reuben S. Harris, Mark T. Liddament, Retroviral restriction by APOBEC proteins Nature Reviews Immunology. ,vol. 4, pp. 868- 877 ,(2004) , 10.1038/NRI1489

Nzovu K. Ulenga, Abdoulaye Dieng Sarr, Donald Hamel, Jean-Louis Sankale, Souleymane Mboup, Phyllis J. Kanki, The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals. AIDS Research and Human Retroviruses. ,vol. 24, pp. 1285- 1290 ,(2008) , 10.1089/AID.2008.0072

Vanessa B Soros, Wes Yonemoto, Warner C Greene, Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. PLOS Pathogens. ,vol. 3, ,(2007) , 10.1371/JOURNAL.PPAT.0030015